News | Digital Radiography (DR) | September 22, 2017

Fujifilm Installing New DR Equipment for Three Large Healthcare Systems

Company will provide mobile and fixed solutions as well as mammography with digital breast tomosynthesis

Fujifilm Installing New DR Equipment for Three Large Healthcare Systems

September 22, 2017 — Fujifilm Medical Systems U.S.A. Inc. recently closed new contracts to enhance diagnostic imaging capabilities for existing customers across the United States. Three healthcare systems will implement Fujifilm’s imaging solutions including mobile digital radiography (DR) systems (FDR Go), the newest DR detector (FDR D-EVO II), DR rooms (FDR Clinica Series of Components) and Fujifilm’s newest mammography solution, the Aspire Cristalle with Digital Breast Tomosynthesis (DBT).

Recently, the company collaborated with the following health providers:

  • Assured Imaging LLC (Tucson, Ariz.) — A leading provider of mobile digital mammography in the United States. In June 2017, Assured Imaging installed the first two Aspire Cristalle systems with 3-D breast imaging in their imaging centers located in Scottsdale, Ariz., and Los Lunas, N.M., of several units planned for the year.
  • Boston Children’s Hospital — As a 404-bed comprehensive center for pediatric healthcare, Boston Children’s is one of the largest pediatric medical centers in the United States. In May 2017, Boston Children’s installed the world’s first single exposure long-length DR detector, the D-EVO GL long-length panel (17x49), with Fujifilm’s Virtual Grid image processing software.
  • Christus Mother Frances Hospital - Tyler (Tyler, Texas) — A 402-bed acute care facility that offers a complete range of services including Tyler’s first neonatal intensive care unit. In June 2017, Christus Mother Frances Hospital - Tyler installed six FDR Go’s with D-EVO II detectors as well as one additional in the CMFH-Jacksonville acute care hospital.

 

For more information: www.fujimed.com

Related Content

IBM collected a dataset of 52,936 images from 13,234 women who underwent at least one mammogram between 2013 and 2017.

IBM collected a dataset of 52,936 images from 13,234 women who underwent at least one mammogram between 2013 and 2017, and who had health records for at least one year prior to the mammogram. The algorithm was trained on 9,611 mammograms. Image courtesy of Radiology.

Feature | Artificial Intelligence | July 19, 2019 | Michal Chorev
Breast cancer is the global leading cause of cancer-related deaths in women, and the most commonly diagnosed cancer...
Advances in long-length digital radiography are creating opportunities for visualization during spinal surgery, as well as pre- and post-operatively. Image courtesy of Fujifilm Medical Systems

Advances in long-length digital radiography are creating opportunities for visualization during spinal surgery, as well as pre- and post-operatively. Image courtesy of Fujifilm Medical Systems

Feature | Digital Radiography (DR) | July 19, 2019 | By Greg Freiherr
Recent advances in...
Low Doses of Radiation Promote Cancer-capable Cells
News | Radiation Dose Management | July 18, 2019
Low doses of radiation equivalent to three computed tomography (CT) scans, which are considered safe, give cancer-...
Paragon Biosciences Launches Qlarity Imaging to Advance FDA-cleared AI Breast Cancer Diagnosis System

Qlarity Imaging’s software is used to assist radiologists in the assessment and characterization of breast lesions. Imaging features are synthesized by an artificial intelligence algorithm into a single value, the QI score, which is analyzed relative to a database of reference abnormalities with known ground truth. Image courtesy of Business Wire.

Technology | Artificial Intelligence | July 18, 2019
Paragon Biosciences LLC announced the launch of its seventh portfolio company, Qlarity Imaging LLC, which was founded...
FDA Clears Koios DS Breast 2.0 AI-based Software
News | Ultrasound Women's Health | July 11, 2019
Koios Medical announced its second 510(k) clearance from the U.S. Food and Drug Administration (FDA).
SimonMed Imaging Implements ProFound AI for 3-D Tomosynthesis
News | Mammography | July 10, 2019
Arizona-based SimonMed Imaging announced their implementation of the first U.S. Food and Drug Administration (FDA)-...
Therapixel Appoints Matthieu Leclerc-Chalvet as CEO
News | Artificial Intelligence | July 03, 2019
Artificial intelligence (AI) breast cancer screening specialist Therapixel announced the appointment of Matthieu...
GE Healthcare showcases Senographe Pristina Serena featuring its add-on-biopsy kit at the Breast Imaging Symposium. Photo by Greg Freiherr

GE Healthcare showcases Senographe Pristina Serena featuring its add-on-biopsy kit at the Breast Imaging Symposium. Photo by Greg Freiherr

Feature | Breast Imaging | July 03, 2019 | By Greg Freiherr
Productivity and its enabler — efficiency — guided the display of products at the April...
Countless possibilities can impact the future of global healthcare and AI is the first step toward breakthrough that will change the landscape of personalized medicine
Feature | Women's Health | July 03, 2019 | By Samir Parikh
Contrary to what many people believe,...

Image courtesy of GE Healthcare

Feature | Radiology Business | July 03, 2019 | By Jeffrey Hoffmeister, M.D.
Burnout in the medical profession is not uncommon, particularly as clinicians have become more overwhelmed by growing